CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Percutaneous Support Devices for Percutaneous Coronary Intervention A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention) Significantly less inappropriate shocks in ischemic patients compared to non-ischemic patients: The S-ICD experience of a high volume single-center Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock

Editorial2019 Jan 15;139(3):347-350.

JOURNAL:Circulation. Article Link

Percutaneous Support Devices for Percutaneous Coronary Intervention

Patel MR. Keywords: drug-eluting stents; STEMI without cardiogenic shock ; myocardial reperfusion; percutaneous coronary intervention; percutaneous support devices

FULL TEXT PDF